The Microbiology of Postoperative Peritonitis

Postoperative peritonitis carries a higher risk of complications and mortality than does community-acquired disease. Little, however, is known about the specific microbiology of this condition. To gain insight into this problem, the microbiological findings of 67 patients with postoperative peritoni...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2001-11, Vol.33 (9), p.1513-1519
Hauptverfasser: Roehrborn, A., Thomas, L., Potreck, O., Ebener, C., Ohmann, C., Goretzki, P. E., Röher, H. D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1519
container_issue 9
container_start_page 1513
container_title Clinical infectious diseases
container_volume 33
creator Roehrborn, A.
Thomas, L.
Potreck, O.
Ebener, C.
Ohmann, C.
Goretzki, P. E.
Röher, H. D.
description Postoperative peritonitis carries a higher risk of complications and mortality than does community-acquired disease. Little, however, is known about the specific microbiology of this condition. To gain insight into this problem, the microbiological findings of 67 patients with postoperative peritonitis were compared with those of 68 patients with community-acquired peritonitis. In a comparison of postoperative peritonitis with community-acquired disease, the number of isolates of enterococci (23 versus 6) and Enterobacter species (13 versus 4) were increased and the number of isolates of Escherichia coli (21 versus 42) were reduced. Antibiotic therapy before reintervention increased the number of resistant organisms at relaparotomy (33% versus 8%). The in vitro efficacy of the primary antibiotic or combination of drugs did not affect mortality rates (40% versus 38% after effective and ineffective treatment, respectively). Thus, the microbiology of postoperative peritonitis differs significantly from that of community-acquired disease, and specific antibiotic therapy is required, despite the doubtful impact on survival.
doi_str_mv 10.1086/323333
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72173085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4482821</jstor_id><oup_id>10.1086/323333</oup_id><sourcerecordid>4482821</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-a5d17f9aaecd3d549657032d5e73d678aadc046f338d87edaace919e8da69d5d3</originalsourceid><addsrcrecordid>eNqF0M9LwzAUB_AgitOpf4HIPOitmjRN8nqU-WPCxAlTh5eQNalmdstMWnH_vR0d20nMJYH34b2XL0JHBF8QDPySxrQ-W2iPMCoizlKyXb8xgygBCi20H8IEY0IAs13UIoRxAEb2UDT8MJ0Hm3k3tq5w74uOyzsDF0o3N16V9tt0Bsbb0s1sacMB2slVEczh6m6j59ubYbcX9R_v7rtX_ShLGC0jxTQReaqUyTTVLEk5E5jGmhlBNReglM5wwnNKQYMwWqnMpCQ1oBVPNdO0jc6bvnPvvioTSjm1ITNFoWbGVUGKmAiKgf0LCdQL0Rg2sP5pCN7kcu7tVPmFJFguE5RNgjU8WXWsxlOjN2wVWQ3OVkCFTBW5V7PMho1LSMwx5rU7bZyr5n8PO27MpA7cr1WSQAzxclTUlG0ozc-6rPyn5IIKJnujN3k9eO2-jJ5A9ugvIi-Znw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18453328</pqid></control><display><type>article</type><title>The Microbiology of Postoperative Peritonitis</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Roehrborn, A. ; Thomas, L. ; Potreck, O. ; Ebener, C. ; Ohmann, C. ; Goretzki, P. E. ; Röher, H. D.</creator><creatorcontrib>Roehrborn, A. ; Thomas, L. ; Potreck, O. ; Ebener, C. ; Ohmann, C. ; Goretzki, P. E. ; Röher, H. D.</creatorcontrib><description>Postoperative peritonitis carries a higher risk of complications and mortality than does community-acquired disease. Little, however, is known about the specific microbiology of this condition. To gain insight into this problem, the microbiological findings of 67 patients with postoperative peritonitis were compared with those of 68 patients with community-acquired peritonitis. In a comparison of postoperative peritonitis with community-acquired disease, the number of isolates of enterococci (23 versus 6) and Enterobacter species (13 versus 4) were increased and the number of isolates of Escherichia coli (21 versus 42) were reduced. Antibiotic therapy before reintervention increased the number of resistant organisms at relaparotomy (33% versus 8%). The in vitro efficacy of the primary antibiotic or combination of drugs did not affect mortality rates (40% versus 38% after effective and ineffective treatment, respectively). Thus, the microbiology of postoperative peritonitis differs significantly from that of community-acquired disease, and specific antibiotic therapy is required, despite the doubtful impact on survival.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/323333</identifier><identifier>PMID: 11568851</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University Chicago Press</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Bacteria ; Bacterial diseases ; Bacterial diseases of the digestive system and abdomen ; Biological and medical sciences ; Enterobacter ; Human bacterial diseases ; Humans ; Infections ; Infectious diseases ; Major Articles ; Medical sciences ; Microbiology ; Mortality ; Peritonitis ; Peritonitis - drug therapy ; Peritonitis - microbiology ; Staphylococcus ; Surgical Wound Infection - drug therapy ; Surgical Wound Infection - microbiology</subject><ispartof>Clinical infectious diseases, 2001-11, Vol.33 (9), p.1513-1519</ispartof><rights>Copyright 2001 The Infectious Diseases Society of America</rights><rights>2001 by the Infectious Diseases Society of America 2001</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-a5d17f9aaecd3d549657032d5e73d678aadc046f338d87edaace919e8da69d5d3</citedby><cites>FETCH-LOGICAL-c453t-a5d17f9aaecd3d549657032d5e73d678aadc046f338d87edaace919e8da69d5d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4482821$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4482821$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14126006$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11568851$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roehrborn, A.</creatorcontrib><creatorcontrib>Thomas, L.</creatorcontrib><creatorcontrib>Potreck, O.</creatorcontrib><creatorcontrib>Ebener, C.</creatorcontrib><creatorcontrib>Ohmann, C.</creatorcontrib><creatorcontrib>Goretzki, P. E.</creatorcontrib><creatorcontrib>Röher, H. D.</creatorcontrib><title>The Microbiology of Postoperative Peritonitis</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>Postoperative peritonitis carries a higher risk of complications and mortality than does community-acquired disease. Little, however, is known about the specific microbiology of this condition. To gain insight into this problem, the microbiological findings of 67 patients with postoperative peritonitis were compared with those of 68 patients with community-acquired peritonitis. In a comparison of postoperative peritonitis with community-acquired disease, the number of isolates of enterococci (23 versus 6) and Enterobacter species (13 versus 4) were increased and the number of isolates of Escherichia coli (21 versus 42) were reduced. Antibiotic therapy before reintervention increased the number of resistant organisms at relaparotomy (33% versus 8%). The in vitro efficacy of the primary antibiotic or combination of drugs did not affect mortality rates (40% versus 38% after effective and ineffective treatment, respectively). Thus, the microbiology of postoperative peritonitis differs significantly from that of community-acquired disease, and specific antibiotic therapy is required, despite the doubtful impact on survival.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the digestive system and abdomen</subject><subject>Biological and medical sciences</subject><subject>Enterobacter</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Major Articles</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Mortality</subject><subject>Peritonitis</subject><subject>Peritonitis - drug therapy</subject><subject>Peritonitis - microbiology</subject><subject>Staphylococcus</subject><subject>Surgical Wound Infection - drug therapy</subject><subject>Surgical Wound Infection - microbiology</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0M9LwzAUB_AgitOpf4HIPOitmjRN8nqU-WPCxAlTh5eQNalmdstMWnH_vR0d20nMJYH34b2XL0JHBF8QDPySxrQ-W2iPMCoizlKyXb8xgygBCi20H8IEY0IAs13UIoRxAEb2UDT8MJ0Hm3k3tq5w74uOyzsDF0o3N16V9tt0Bsbb0s1sacMB2slVEczh6m6j59ubYbcX9R_v7rtX_ShLGC0jxTQReaqUyTTVLEk5E5jGmhlBNReglM5wwnNKQYMwWqnMpCQ1oBVPNdO0jc6bvnPvvioTSjm1ITNFoWbGVUGKmAiKgf0LCdQL0Rg2sP5pCN7kcu7tVPmFJFguE5RNgjU8WXWsxlOjN2wVWQ3OVkCFTBW5V7PMho1LSMwx5rU7bZyr5n8PO27MpA7cr1WSQAzxclTUlG0ozc-6rPyn5IIKJnujN3k9eO2-jJ5A9ugvIi-Znw</recordid><startdate>20011101</startdate><enddate>20011101</enddate><creator>Roehrborn, A.</creator><creator>Thomas, L.</creator><creator>Potreck, O.</creator><creator>Ebener, C.</creator><creator>Ohmann, C.</creator><creator>Goretzki, P. E.</creator><creator>Röher, H. D.</creator><general>The University Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20011101</creationdate><title>The Microbiology of Postoperative Peritonitis</title><author>Roehrborn, A. ; Thomas, L. ; Potreck, O. ; Ebener, C. ; Ohmann, C. ; Goretzki, P. E. ; Röher, H. D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-a5d17f9aaecd3d549657032d5e73d678aadc046f338d87edaace919e8da69d5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the digestive system and abdomen</topic><topic>Biological and medical sciences</topic><topic>Enterobacter</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Major Articles</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Mortality</topic><topic>Peritonitis</topic><topic>Peritonitis - drug therapy</topic><topic>Peritonitis - microbiology</topic><topic>Staphylococcus</topic><topic>Surgical Wound Infection - drug therapy</topic><topic>Surgical Wound Infection - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roehrborn, A.</creatorcontrib><creatorcontrib>Thomas, L.</creatorcontrib><creatorcontrib>Potreck, O.</creatorcontrib><creatorcontrib>Ebener, C.</creatorcontrib><creatorcontrib>Ohmann, C.</creatorcontrib><creatorcontrib>Goretzki, P. E.</creatorcontrib><creatorcontrib>Röher, H. D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roehrborn, A.</au><au>Thomas, L.</au><au>Potreck, O.</au><au>Ebener, C.</au><au>Ohmann, C.</au><au>Goretzki, P. E.</au><au>Röher, H. D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Microbiology of Postoperative Peritonitis</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2001-11-01</date><risdate>2001</risdate><volume>33</volume><issue>9</issue><spage>1513</spage><epage>1519</epage><pages>1513-1519</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>Postoperative peritonitis carries a higher risk of complications and mortality than does community-acquired disease. Little, however, is known about the specific microbiology of this condition. To gain insight into this problem, the microbiological findings of 67 patients with postoperative peritonitis were compared with those of 68 patients with community-acquired peritonitis. In a comparison of postoperative peritonitis with community-acquired disease, the number of isolates of enterococci (23 versus 6) and Enterobacter species (13 versus 4) were increased and the number of isolates of Escherichia coli (21 versus 42) were reduced. Antibiotic therapy before reintervention increased the number of resistant organisms at relaparotomy (33% versus 8%). The in vitro efficacy of the primary antibiotic or combination of drugs did not affect mortality rates (40% versus 38% after effective and ineffective treatment, respectively). Thus, the microbiology of postoperative peritonitis differs significantly from that of community-acquired disease, and specific antibiotic therapy is required, despite the doubtful impact on survival.</abstract><cop>Chicago, IL</cop><pub>The University Chicago Press</pub><pmid>11568851</pmid><doi>10.1086/323333</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2001-11, Vol.33 (9), p.1513-1519
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_72173085
source Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Anti-Bacterial Agents - therapeutic use
Antibiotics
Bacteria
Bacterial diseases
Bacterial diseases of the digestive system and abdomen
Biological and medical sciences
Enterobacter
Human bacterial diseases
Humans
Infections
Infectious diseases
Major Articles
Medical sciences
Microbiology
Mortality
Peritonitis
Peritonitis - drug therapy
Peritonitis - microbiology
Staphylococcus
Surgical Wound Infection - drug therapy
Surgical Wound Infection - microbiology
title The Microbiology of Postoperative Peritonitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T20%3A09%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Microbiology%20of%20Postoperative%20Peritonitis&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Roehrborn,%20A.&rft.date=2001-11-01&rft.volume=33&rft.issue=9&rft.spage=1513&rft.epage=1519&rft.pages=1513-1519&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/323333&rft_dat=%3Cjstor_proqu%3E4482821%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18453328&rft_id=info:pmid/11568851&rft_jstor_id=4482821&rft_oup_id=10.1086/323333&rfr_iscdi=true